The HER2 Spectrum: Diagnostic Precision in Metastatic Breast Cancer for Real-World Impact

Header Menu

Home

Header Menu

Home

The HER2 Spectrum

Diagnostic Precision in Metastatic Breast Cancer for Real-World Impact

Polling
Swing-o-meter
Q&A
Evaluation Form

Polling

Swing-o-meter

Image

Image

Image

Image

Image

Image

Image

Image

Image

Image

Image

Image

Artifact or real stain?

Artifact

Real stain

Q&A

Your Question

Leave this field blank

Evaluation Form

Thank you for attending our Satellite Symposium. Please take a few minutes to answer this questionnaire. Your answers are important to us and will assist us in evaluating the success of this programme and planning future events.

An asterisk (*) indicates a required question

1. Please provide your country of residence

2. Please provide your area of specialty (e.g., pathologist, medical oncologist, etc.)

3. How would you evaluate the following?

Satellite Symposium overall?

Excellent

Good

Fair

Poor

Unsatisfactory

Content of the presentations?

Excellent

Good

Fair

Poor

Unsatisfactory

Panel discussion?

Excellent

Good

Fair

Poor

Unsatisfactory

4. Following this symposium, how confident are you in implementing HER2-low and HER2-ultralow testing within your institution?

Very confident

Confident

Somewhat Confident

Not Confident

5. Following this symposium, how confident do you feel discussing the clinical implications of HER2-low and HER2-ultralow testing with multidisciplinary colleagues and patients?

Very confident

Confident

Somewhat Confident

Not Confident

6. As a result of this symposium, do you plan to discuss the implementation of HER2-low and HER2-ultralow testing with your pathology and/or medical oncology colleagues?

Yes

Our institution already performs HER2-low and HER2-ultralow testing

Other

Please specify

7. If a similar Daiichi Sankyo/AstraZeneca symposium was offered in the future – how likely are you to recommend it to a colleague?

Very Likely

Likely

Somewhat Likely

Not Likely

8. Please provide any topics you would like to see included in future presentations or symposia, or any additional comments

Leave this field blank

MED-EU-TRAS-00074 | 07/26

This non-promotional satellite symposium is organised and funded by Daiichi Sankyo and AstraZeneca and is intended for HCPs only.
© Daiichi Sankyo Europe GmbH, Zielstattstr. 48, 81379 Munich, Germany. www.daiichi-sankyo.eu and AstraZeneca. www.astrazeneca.com
All rights reserved

Header Menu

Home

How was your overall experience today?

Leave this field blank